EICHORCondition: Depression, Postpartum · Postpartum Depression · Post-partum Depression · Sponsor: TWi Biotechnology, Inc.
The purpose of this research study is to test the study drug, NORA520, as a possible treatment for severe postpartum depression (PPD). The trial aims to determine: * How well NORA520 is tolerated and what side effects it may cause * If NORA520 reduces depressive symptoms in subjects with severe PPD * The amount of NORA520 in the blood at various times after taking the study drug; this provides information that helps determine how often NORA520 should be taken * In a subset of subjects, the amount of NORA520 in breastmilk at various times after taking it to determine if and how much NORA520 can pass into breastmilk Participate in this study will be randomly assigned to one of 3 different groups. All subjects will take the study drug for 3 days.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pillar Clinical Research | Bentonville, Arkansas, United States | — |
| Advanced Research Center | Anaheim, California, United States | — |
| Alliance Research Institute | Canoga Park, California, United States | — |
| Cenexel Clinical Research | Sherman Oaks, California, United States | — |
| Cenexel Clinical Research | Torrance, California, United States | — |
| MedOne Clinical Research | Miami, Florida, United States | — |
| Meridian International Research, Inc. | Miami Gardens, Florida, United States | — |
| Combined Research | Orlando, Florida, United States | — |
| Clinical Research Center of Florida | Pompano Beach, Florida, United States | — |
| GCP Research | St. Petersburg, Florida, United States | — |
| Cenexel Clinical Research | Atlanta, Georgia, United States | — |
| CenExel Clinical Research | Decatur, Georgia, United States | — |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06285916